Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000229557 | SCV000290294 | benign | Adams-Oliver syndrome 5 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000293191 | SCV000339114 | likely benign | not specified | 2016-02-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000293191 | SCV000525647 | benign | not specified | 2016-10-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV002313954 | SCV000738411 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-10-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Human Genetics, |
RCV000660175 | SCV000782169 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000229557 | SCV002554247 | benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270055 | SCV002554248 | benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001726067 | SCV003799930 | benign | not provided | 2023-06-14 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000293191 | SCV004029540 | benign | not specified | 2023-07-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001726067 | SCV004161998 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | NOTCH1: BP4, BP7, BS2 |
Prevention |
RCV004532950 | SCV004735033 | benign | NOTCH1-related disorder | 2019-06-10 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Breakthrough Genomics, |
RCV001726067 | SCV005228662 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV000293191 | SCV001807249 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001726067 | SCV001967391 | likely benign | not provided | no assertion criteria provided | clinical testing |